Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency

American Journal of Cardiology

Volumn 89, Issue 10, 2002, Pages 1209-1211

  Jeremias, Allen ^a   Bhatt, Deepak L ^a   Chew, Derek P ^a   Ziada, Khaled M ^a   Albirini, Abdulhay ^a   Brener, Sorin J ^a   Lincoff, A Michael ^a   Topol, Eric J ^a   Ellis, Stephen G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; TICLOPIDINE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; BODY WEIGHT; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA BASE; DISEASE ASSOCIATION; DOSE CALCULATION; DRUG SAFETY; DRUG SCREENING; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEMODIALYSIS; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RISK FACTOR; STATISTICS; STENT; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERIOSCLEROSIS; DRUG EVALUATION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OHIO; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POSTOPERATIVE HEMORRHAGE; RISK FACTORS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0037094157     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02308-1     Document Type: Article

References (12)

1. Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure
2. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation
3. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
4. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II
5. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein- IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting
6. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients
7. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients
8. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients
9. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?
10. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
11. The safety of abciximab before percutaneous coronary revascularization in patients with chronic renal insufficiency